Torsades de Pointes

A complete reference on the epidemiology, drug culprits, mechanisms, risk factors, and methods of prevention and management of the life-threatening polymorphic ventricular tachycardia known as torsades de pointes

James E. Tisdale (Edited by)

9780128214466

Paperback, published 17 March 2022

376 pages, 100 illustrations (50 in full color)
27.6 x 21.6 x 2.4 cm, 1.02 kg

Approx.360 pages

1. Overview of torsades de pointes 2. Torsades de pointes associated with inherited channelopathies 3. Drug-induced torsades de pointes 4. Mechanisms of torsades de pointes 5. Traditional risk factors for QT interval prolongation and torsades de pointes 6. Emerging risk factors for QT interval prolongation and torsades de pointes 7. Predictive analytics for reducing the risk of QT interval prolongation and torsades de pointes 8. Antiarrhythmic agents and torsades de pointes 9. Psychotropic agents and torsades de pointes 10. Antimicrobial agents and torsades de pointes 11. Methadone, synthetic opioids and torsades de pointes 12. Torsades de pointes in patients with cancer 13. Strategies for prevention and management of QT interval prolongation and torsades de pointes 14. Important unanswered research questions related to torsades de pointes

Subject Areas: Life sciences: general issues [PSA]